Onkologie. 2024:18(5):311-314 | DOI: 10.36290/xon.2024.064
HIPEC - ovarian cancer case report
- Oddělení gynekologické onkologie, Klinika operační onkologie, Masarykův onkologický ústav Brno
Hyperthermic intraperitoneal chemotherapy (HIPEC), as a possible part of a radical cytoreductive surgery for ovarial cancer with responce or stable state after neoadjuvant chemotherapy, from 2018 due to results of game changing study is getting more focus. As a part of management of patients with ovarial cancer with the possibility to ad HIPEC to cytoreductive surgery with R0 resection.
Keywords: HIPEC, ovarial cancer, cytoreduction, IDS, hyperthermy.
Accepted: November 18, 2024; Published: November 28, 2024 Show citation
References
- Vergote I, du Bois A, Amant F, et al. Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree? Gynecol Oncol. 2013;128(1):6-11. doi: 10.1016/j.ygyno.2012.09.013. Epub 2012 Sep 21. PMID: 23006973.
Go to original source... 
Go to PubMed... - Bhatt A, Glehen O, Zivanovic O, et al. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Epithelial Ovarian Cancer. Ann Surg Oncol. 2023;30(13):8115-8137. doi: 10.1245/s10434-023-13932-3. Epub 2023 Aug 10. PMID: 37561343. Go to original source... Go to PubMed...
- van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med. 2018378(3):230-240. doi: 10.1056/NEJMoa1708618. PMID: 29342393. Go to original source... Go to PubMed...
- Spriggs DR, Zivanovic O. Ovarian Cancer Treatment - Are We Getting Warmer? N Engl J Med. 2018;378(3):293-294. doi: 10.1056/NEJMe1714556. PMID: 29342385. Go to original source... Go to PubMed...
- Aronson SL, Lopez-Yurda M, Koole SN, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial. Lancet Oncol. 2023;24(10):1109-1118. doi: 10.1016/S1470-2045(23)00396-0. Epub 2023 Sep 11. PMID: 37708912. Go to original source... Go to PubMed...
- Lim MC, Chang SJ, Park B, et al. Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial. JAMA Surg. 2022;157(5):374-383. doi: 10.1001/jamasurg.2022.0143. PMID: 35262624; PMCID: PMC8908225. Go to original source... Go to PubMed...
- Chan JK, Brady MF, Penson RT, et al. Weekly vs. every-3-week paclitaxel and carboplatin for ovarian cancer. New England Journal of Medicine. 2016;374(8):738-748. doi: 10.1056/NEJMoa1516217. Go to original source...